Source:http://linkedlifedata.com/resource/pubmed/id/19090767
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-1-15
|
pubmed:abstractText |
Twenty-nine derivatives of berberine (1) or pseudoberberine (2) were designed, semisynthesized, and evaluated for their up-regulatory activity on the low-density-lipoprotein receptor (LDLR) expression. SAR analysis revealed that (i) the methylenedioxy group at the 2- and 3-position is an essential element to keep the activity, (ii) the 7-position quaternary ammonium and planar structure of the compound are activity-required, and (iii) addition of electron-donating groups at the 7- or 13-position reduced the activity. Of the compound 1 analogues, compound 2 exhibited an increased activity on LDLR expression compared to 1. In the hyperlipidemic rats, compound 2 (100 (mg/kg)/day) reduced blood CHO and LDL-c by 42.6% and 49.4%, respectively, more efficient than 1 did (p < 0.01 for both). The results were confirmed in the hyperlipidemic mice. LD(50) of 2 in mice was over 5000 mg/kg (oral). We consider compound 2 a promising cholesterol-lowering drug candidate.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1520-4804
|
pubmed:author |
pubmed-author:Chang-QinHuH,
pubmed-author:DuNa-NaNN,
pubmed-author:FengYan-ChunYC,
pubmed-author:GaoHongH,
pubmed-author:GaoLi-MeiLM,
pubmed-author:JiangJian-DongJD,
pubmed-author:KongWei-JiaWJ,
pubmed-author:LiYing-HongYH,
pubmed-author:LiuYingY,
pubmed-author:SongDan-QingDQ,
pubmed-author:WangYan-XiangYX,
pubmed-author:WangYue-MingYM,
pubmed-author:YangPengP,
pubmed-author:ZuoZeng-YanZY
|
pubmed:issnType |
Electronic
|
pubmed:day |
22
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
492-501
|
pubmed:meshHeading |
pubmed-meshheading:19090767-Animals,
pubmed-meshheading:19090767-Berberine,
pubmed-meshheading:19090767-Cholesterol,
pubmed-meshheading:19090767-Hepatocytes,
pubmed-meshheading:19090767-Humans,
pubmed-meshheading:19090767-Hypercholesterolemia,
pubmed-meshheading:19090767-Magnetic Resonance Spectroscopy,
pubmed-meshheading:19090767-Male,
pubmed-meshheading:19090767-Mass Spectrometry,
pubmed-meshheading:19090767-Mice,
pubmed-meshheading:19090767-Mice, Inbred C57BL,
pubmed-meshheading:19090767-Models, Molecular,
pubmed-meshheading:19090767-RNA, Messenger,
pubmed-meshheading:19090767-Rats,
pubmed-meshheading:19090767-Receptors, LDL,
pubmed-meshheading:19090767-Structure-Activity Relationship,
pubmed-meshheading:19090767-Up-Regulation
|
pubmed:year |
2009
|
pubmed:articleTitle |
Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy.
|
pubmed:affiliation |
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|